Autologous cell based therapy for treating chronic infarct myocardium

Clinical Hemorheology and Microcirculation

Volumn 33, Issue 3, 2005, Pages 263-268

  Tran, Nguyen ^a   Marie, Pierre Yves ^b   Nloga, Joseph ^a   Mascali, Fatiha ^b   Franken, Philippe ^c   Lahoutte, Tony ^c   Li, Yan ^a   Antunes, Laurent ^b   El Jaafari, Assia ^a   Bensoussan, Daniele ^a   Stoltz, Jean François ^a   Villemot, Jean Pierre ^a  

^a UNIVERSITÉ DE LORRAINE   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ADOPTIVE IMMUNOTHERAPY; AUTOLOGOUS STEM CELL TRANSPLANTATION; BIOAVAILABILITY; CELL TRANSPLANTATION; CELLULAR DISTRIBUTION; CONFERENCE PAPER; HEART FUNCTION; HEART INFARCTION; HEART MUSCLE CONTRACTILITY; HEMATOPOIETIC STEM CELL; ISCHEMIC HEART DISEASE; METHODOLOGY; MYOBLAST;

ANIMALS; BONE MARROW TRANSPLANTATION; CELL MOVEMENT; CHRONIC DISEASE; HUMANS; MYOBLASTS, SKELETAL; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 26444488514     PISSN: 13860291     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (13)

1. A. Aicher, W. Brenner, M. Zuhayra et al., Assessment of the tissue distribution of transplanted human endothelial progenitor cells by radioactive labeling, Circulation 107 (2003), 2134-2139.
2. I.M. Barbash, P. Chouraqui, J. Baron et al., Systemic delivery of bone marrow-derived mesenchymal stem cells to the infarcted myocardium: feasibility, cell migration, and body distribution, Circulation 108 (2003), 863-888.
3. W. Brenner, A. Aicher, T. Eckey et al., 111In-labeled CD34+ hematopoietic progenitor cells in a rat myocardial infarction model, J. Nucl. Med. 45 (2004), 512-518.
4. I.M. Dixon, S.L. Lee, and N.S. Dhalla, Nitrendipine binding in congestive heart failure due to myocardial infarction, Circ. Res. 66 (1990), 782-788.
5. B.H. Duncan, A.W. Ahlberg, M.G. Levine et al., Comparison of electrocardiographic-gated technetium-99m sestamibi single-photon emission computed tomographic imaging and rest-redistribution thallium-201 in the prediction of myocardial viability, Am. J. Cardiol. 85 (2000), 680-684.
6. P. Menasche, A.A. Hagege, M. Scorsin et al., Myoblast transplantation for heart failure, Lancet 357 (2001), 279-280.
7. R.A. Mulinari, I. Gavras, Y.X. Wang et al., Effects of a vasopressin antagonist with combined antipressor and antiantidiuretic activities in rats with left ventricular dysfunction, Circulation 81 (1990), 308-311.
8. D. Orlic, J. Kajstura, S. Chimenti et al., Mobilized bone marrow cells repair the infarcted heart, improving function and survival, Proc. Natl. Acad. Sci. USA 98 (2001), 10344-10349.
9. E.C. Perin, H.F. Dohmann, R. Borojevic et al., Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure, Circulation 107 (2003), 2294-2302.
10. B.E. Strauer, M. Brehm, T. Zeus et al., Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans, Circulation 106 (2002), 1913-1918.
11. R.B. Thompson, S.M. Emani, B.H. Davis et al., Comparison of intracardiac cell transplantation: autologous skeletal myoblasts versus bone marrow cells, Circulation 108 (Suppl. 1) (2003), II264-II271.
12. J.E. Udelson, P.S. Coleman, J. Metherall et al., Predicting recovery of severe regional ventricular dysfunction. Comparison of resting scintigraphy with 201T1 and 99mTc-sestamibi, Circulation 89 (1994), 2552-2561.
13. C. Vanhove, T. Lahoutte, M. Defrise et al., Reproducibility of left ventricular volumes and ejection fraction measurements in rats using pinhole gated SPECT, Eur. J. Nucl. Med. Mol. Imaging (full article in the final revision process) (2004).